CN Patent

CN111362922A — 2,4-二氨基嘧啶衍生物及其用途

Assigned to Shanghai Zheye Biotechnology LLC · Expires 2020-07-03 · 6y expired

What this patent protects

本发明涉及一类2,4‑二氨基嘧啶衍生物，其药学上可接受的盐、水合物、溶剂化物或立体异构体，及其制备方法以及该类化合物单独或与其他药物联合使用在治疗具有ALK2激酶介导的病理学特征的疾病中的应用。

USPTO Abstract

本发明涉及一类2,4‑二氨基嘧啶衍生物，其药学上可接受的盐、水合物、溶剂化物或立体异构体，及其制备方法以及该类化合物单独或与其他药物联合使用在治疗具有ALK2激酶介导的病理学特征的疾病中的应用。

Drugs covered by this patent

Patent Metadata

Patent number
CN111362922A
Jurisdiction
CN
Classification
—
Expires
2020-07-03
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Zheye Biotechnology LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.